From the Journals

New study establishes IBD severity index


 

FROM GUT


The exercise first had participants decide which hypothetical patient profiles met their evaluation criteria; it then showed them two final profiles and asked which was the more severe case. Survey length depended on the consistency of participants’ responses, with those lacking consistency being given more tasks to complete, Dr. Siegel and his colleagues reported.

Respondents completed the exercise three times: first independently without discussion, then after discussion in a group setting with an automated response system, and finally, independently following group discussion. Disease severity indexes were created on a 100-point scale, and average part-worth utility scores were used to determine minimum and maximum scores for each attribute, with zero representing the absence of a symptom.

Crohn’s disease severity was largely dependent on factors related to intestinal damage, whereas ulcerative colitis disease severity was associated with symptoms and effects on daily life.

This analysis “helps redefine overall disease severity for IBD,” the authors wrote. Once validated, the indexes will offer “both further research opportunities and a practical tool by which to classify overall disease severity of patients and offer appropriate treatment without relying on present symptoms alone,” they added.

Recommended Reading

VIDEO: No short-term link found between PPIs, myocardial infarction
MDedge Family Medicine
Ulcerative colitis is disabling over time
MDedge Family Medicine
Newborn oral rotavirus vaccine held effective
MDedge Family Medicine
Guidelines update best practices for hemorrhoid treatment
MDedge Family Medicine
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Family Medicine
Bloating. Flatulence. Think SIBO
MDedge Family Medicine
Strategies to reduce colorectal surgery complications
MDedge Family Medicine
Heart attacks soar in young IBD patients
MDedge Family Medicine
Buy the IBD, get the comorbidity for free
MDedge Family Medicine
Xeljanz: FDA panel recommends ulcerative colitis indication
MDedge Family Medicine